Business
Lilly snags another Massachusetts biotech as local headcount surges past 1,400 - The Business Journals

What the report says
Eli Lilly expands its Massachusetts biotech buying spree with a $2.875 billion deal for Merida Biosciences, its eighth local acquisition since 2024.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Kevin Lyttle, Robbo Ranx land in Uganda ahead of Serendipity Summer SplashSqoop Uganda
KURA Asset Management enters Uganda’s growing investment marketThe Independent Uganda
QNET turns to trust as Uganda’s direct-selling market goes digitalNile Post